Type 1 (Anaphylactic) Hypersensitivity Reaction

  • Hypersensitivity is increased reactivity or increased sensitivity by the animal body to an antigen to which it has been previously exposed.
  • The most widely adopted current classification is that of Coombs and Gellthat designates immunoglobulin-mediated (immediate) hypersensitivity reactions as types I, II, and III, and lymphoid cell-mediated (delayed-type) hypersensitivity/cell-mediated immunity as a type IV reaction.
  • A hypersensitive response (HR) is an anti-pathogen response in plants produced by avr-R system activation that leads to alterations in Ca+ flux, MAPK activation, and NO and ROI formation.

Type 1 (Anaphylactic) Hypersensitivity Reaction

  • Type I hypersensitivity reaction is commonly called allergic or immediate hypersensitivity reaction.
  • This reaction is always rapid, occurring within minutes of exposure to an antigen, and always
    involves IgE-mediated degranulation of basophils or mast cells.
  • Type I reactions are also known as IgE-mediated hypersensitivity reactions.
  • IgE is responsible for sensitizing mast cells and providing recognition of antigen for immediate hypersensitivity reactions.
  • The short time lag between exposure to antigen and onset of clinical symptoms is due to the presence of preformed mediators in the mast cells.
  • Thus, the time taken for these reactions to initiate is minimal, so the onset of symptoms seems to be immediate.
  • Type I reaction can occur in two forms: anaphylaxis and atopy.

Type 1 Hypersensitivity Mechanism

Clinical Manifestations of Type 1 Hypersensitivity

  • A wide variety of hypersensitivity states can be classified as immediate hypersensitivity reactions.
  • Some have a predominantly cutaneous expression (hives or urticaria), others affects the airways (hay fever, asthma), while still others are of a systemic nature.
  • The latter are often designated as anaphylactic reactions, of which anaphylactic shock is the most severe form.
  • The expression of anaphylaxis is species-specific.
  • The guinea pig usually has bronchoconstriction and bronchial edema as predominant expression, leading to death in acute asphyxiation.
  • In the rabbit, on the contrary, the most affected organ is the heart, and the animals die of right heart failure.
  • In man, allergic bronchial asthma in its most severe forms closely resembles the reaction in the guinea pig.
  • Most frequently, human type I hypersensitivity has a localized expression, such as the bronchoconstriction and bronchial edema that characterizes bronchial asthma, the mucosal edema in hay fever, and the skin rash and subcutaneous edema that defines urticaria (hives).
  • The factor(s) involved in determining the target organs that will be affected in different types of immediate hypersensitivity reactions are not well defined, but the route of exposure to the challenging antigen seems an important factor.
  • For example, allergic (extrinsic) asthma and hay fever are usually associated with inhaled antigens while urticaria is seen as a frequent manifestation of food allergy.
  • However, the manifestations of food allergy are very diverse, and, in addition to hives, can include a variety of symptoms affecting different organs and systems.
  • Systemic Anaphylaxis

    • Systemic anaphylaxis is usually associated with antigens that are directly introduced into the systemic circulation, such as in the case of hypersensitivity to insect venom or to systemically-administered drugs, such as penicillin.
    • However, seafood and peanuts can also elicit anaphylactic reactions.
    • Systemic anaphylactic reactions in humans can present in diverse forms, affecting different organs and systems.
    • Cardiovascular involvement is associated with the highest mortality rates.
  • Atopy

    • Some individuals have an obvious tendency to develop hypersensitivity reactions.
    • The term atopy is used to designate this tendency of some individuals to become sensitized to a variety of allergens (antigens involved in allergic reactions) including pollens, spores, animal danders, house dust, and foods.
    • These individuals, when skin tested, are positive to several allergens and successful therapy must take this multiple reactivity into account.
    • A genetic background for atopy is suggested by the fact that this condition shows familial prevalence.

Pathogenesis of Type 1 Hypersensitivity

  • Immediate hypersensitivity reactions are a consequence of the predominant synthesis of specific IgE antibodies by the allergic individual; these IgE antibodies bind with high affinity to the membranes of basophils and mast cells.
  • When exposed to the sensitizing antigen, the reaction with cell-bound IgE triggers the release of histamine through degranulation, and the synthesis of leukotrienes C4, D4, and E4 [this mixture constitutes what was formerly known as slow-reacting substance of anaphylaxis-A].
  • These substances are potent constrictors of smooth muscle and vasodilators and are responsible for the clinical symptoms associated with immediate hypersensitivity.
  • In recent years, it has been shown, mainly through animal studies, that IL-13, released by Th2 cells, can induce clinical manifestations of asthma, independently of IgE and eosinophils.
  • Thus, cell-mediated, IgE-independent mechanisms may also play a pathogenic role in type I hypersensitivity reactions.

Type 1 (Anaphylactic) Hypersensitivity Reaction

About Author

Photo of author

Sagar Aryal, PhD

Dr. Sagar Aryal is a microbiologist, researcher, and science communicator from Nepal. He is also co-founder and Research Head of the Department of Natural Products at the Kathmandu Research Institute for Biological Sciences (KRIBS), where he leads research on natural product discovery and microbial biodiversity. Dr. Aryal earned his Ph.D. in Microbiology from Tribhuvan University, Kathmandu, Nepal, in 2025, supported by a DAAD Research Grant and a University Grants Commission (UGC) Nepal Ph.D. Fellowship. His research interests include Actinomycetes, Myxobacteria, microbial taxonomy, and natural products, particularly the discovery of bioactive compounds with potential pharmaceutical applications. He isolated and identified Nocardia nepalensis, a novel bacterial species from Nepal, contributing to understanding microbial diversity in the region. Dr. Aryal has published more than 16 research articles in international journals and contributed three book chapters to established academic publications. He has presented scientific research findings and developed international research collaborations through visits to more than 18 countries across Asia, Europe, North America, and Oceania. From 2023 to 2025, he served as the American Society for Microbiology (ASM) Young Ambassador to Nepal. Since December 2025, he has served as an Editorial Board Member of Scientific Reports, a Nature Portfolio journal. In recognition of his scientific contributions, Dr. Aryal received the NAST Science and Technology Youth Award 2025 from the Nepal Academy of Science and Technology. He previously received the Frs. Locke and Stiller Research Award (LSRA) for the 2017-2018 cycle from St. Xavier's College, Kathmandu, and a Nepal Academy of Science and Technology (NAST) Research Grant for 2017-2018. Alongside his scientific career, Dr. Aryal has more than 15 years of experience in blogging, content writing, and search engine optimization (SEO).